GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » Cyclically Adjusted PB Ratio

CK Life Sciences International Holdings (HKSE:00775) Cyclically Adjusted PB Ratio : 1.85 (As of Jun. 04, 2025)


View and export this data going back to 2002. Start your Free Trial

What is CK Life Sciences International Holdings Cyclically Adjusted PB Ratio?

As of today (2025-06-04), CK Life Sciences International Holdings's current share price is HK$0.89. CK Life Sciences International Holdings's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec24 was HK$0.48. CK Life Sciences International Holdings's Cyclically Adjusted PB Ratio for today is 1.85.

The historical rank and industry rank for CK Life Sciences International Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

HKSE:00775' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.6   Med: 1.18   Max: 1.94
Current: 1.75

During the past 13 years, CK Life Sciences International Holdings's highest Cyclically Adjusted PB Ratio was 1.94. The lowest was 0.60. And the median was 1.18.

HKSE:00775's Cyclically Adjusted PB Ratio is ranked worse than
53.71% of 674 companies
in the Biotechnology industry
Industry Median: 1.475 vs HKSE:00775: 1.75

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

CK Life Sciences International Holdings's adjusted book value per share data of for the fiscal year that ended in Dec24 was HK$0.365. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is HK$0.48 for the trailing ten years ended in Dec24.

Shiller PE for Stocks: The True Measure of Stock Valuation


CK Life Sciences International Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for CK Life Sciences International Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Cyclically Adjusted PB Ratio Chart

CK Life Sciences International Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.67 1.42 1.57 1.26 0.86

CK Life Sciences International Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.57 - 1.26 - 0.86

Competitive Comparison of CK Life Sciences International Holdings's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, CK Life Sciences International Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Cyclically Adjusted PB Ratio falls into.


;
;

CK Life Sciences International Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

CK Life Sciences International Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.89/0.48
=1.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CK Life Sciences International Holdings's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec24 is calculated as:

For example, CK Life Sciences International Holdings's adjusted Book Value per Share data for the fiscal year that ended in Dec24 was:

Adj_Book=Book Value per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=0.365/118.9447*118.9447
=0.365

Current CPI (Dec24) = 118.9447.

CK Life Sciences International Holdings Annual Data

Book Value per Share CPI Adj_Book
201512 0.423 102.015 0.493
201612 0.443 103.225 0.510
201712 0.480 104.984 0.544
201812 0.444 107.622 0.491
201912 0.435 110.700 0.467
202012 0.491 109.711 0.532
202112 0.469 112.349 0.497
202212 0.433 114.548 0.450
202312 0.436 117.296 0.442
202412 0.365 118.945 0.365

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CK Life Sciences International Holdings  (HKSE:00775) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


CK Life Sciences International Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CK Life Sciences International Holdings Business Description

Traded in Other Exchanges
N/A
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The operating segments of the company are Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D. The company derives maximum revenue from the Nutraceutical segment. The overall product portfolio of the company involves a presence that spans North America and the Asia Pacific.

CK Life Sciences International Holdings Headlines

No Headlines